ArticleAesthetic surgery journal. Open forum2026
Uniform Treatment Protocol With Hybrid Stromal Vascular Fraction and Platelet-Rich Plasma on Micro-Fat Grafting With Facelifting: A Preliminary Retrospective 3D Vectra Observational Study.
Article in Aesthetic surgery journal. Open forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hybrid stromal vascular fraction (SVF), a combination of mechanical SVF (M-SVF) and stromal vascular matrix (M-SVM) fraction, is an alternative method to overcome limitations of low cell counts by conventional mechanical and enzymatic methods. The aim of this report was to observe the volume retention in facial fat grafts enhanced with hybrid M-SVF and platelets in pure platelet-rich plasma (P-PRP). Using a 5:1 v/v ratio, proportional volumes of micro-fat to proportional volumes and quantitative cell counts of M-SVF/M-SVM and PRP were delivered to palpebral-malar groove/malar fat pad units and evaluated by Vectra Analysis for volumetric changes over 12 months. Collective analysis of 9 female patients (average age: 65.6 years) revealed the percentage volume retention increased from baseline to 3 months (54.9%), then progressively declined to its nadir at 5 to 7 months (38.4%), then rebounded to peak percentage values at 10 to 12 months (69.5%),
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.